The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Lets hope it's this time around Bill.
All of those things but I'm a sucker for waiting for the lump of moneyš
P.S. I.B.
They destroyed the value, they diluted the share holding then they consolidated it.
But it's at all time lows and they have just under half the funding left with carrots dangling so i'm back in.
So ... sell on the next spike (it is coming, and I remember you never do) and that could be a mistake ;) ;)
Ib,
You are spot on.
I've been following this story for years, really like the tech.
Not necessarily looking to hit every spike, equally not stayed in when I think they've made "unusual" decisions.
Reason I come back in each time it has settled is because if they get any one of these contracts a little investment is going to become a lump of money.
CC
I don't think that's going to happen. The NHS is renowned for it's slow uptake on all sorts of technological breakthroughs however I'm still of the opinion the pain will hopefully be worth the gain. It's worth the gamble imo because the NHS is the cash cow that keeps on giving. Getting the the right technique to milk said cow can take some refining but once our foot is in the door it's a pretty stable environment. Lucrative as it maybe I'm not sure the same could be said for the private sector longer term.
A mixture of both would be good and let's hope the private contract gives the NHS a kick up the ar#se to pull their finger out. I know you've been in and out of this for ages but I think to sell on the next spike (it is coming, and I remember you always do) could be a mistake. The news in the next few months could come thick and fast given the latest in the press re radiology backlogs. Certainly looks to be an interesting year so let's hope it's Feedbacks' year. gl
Nick Meyhew reposted this post from the NCA, I suspect that they would be using Bleepa for this:
"Our colleagues at the #RoyalOldham have been part of an innovative pilot looking to transform services for children and young people living with asthma and related conditions.
The project takes a whole-household approach to asthma intervention identifying children and young people admitted to hospital with asthma or respiratory illnesses, who smoke or live in a household that smokes."
Ricky Barber, Chidren's Unit Manager explains more....
You can watch the full video
https://orlo.uk/rSGzS
Hi CC, not sure what you mean by 'free' test programmes, all the NHS pilots have created revenue, and not been offered at a discount. The pilots are needed to create the necessary evidence to enable decisions to be made within the NHS. There has to be proof that Bleepa will actually cut waiting times and save money, which we know it does. These two further pilots are going to further prove that Bleepa/Carelocker can be rolled out to other CDCs and the results from QVH replicated. Positive results will lead to Bleepa being rolled out nationally I believe.
Assuming the CDC's don't pick this up and adopt Bleepa by April 2024 with their new fin yr budgets
Leave the NHS, let it do what it does best ( burn cash ) and provide an increasingly second rate service.
Bleep and carelocker is picked up by Private medical and their paymasters the Insurance Co's the same specialists that work in both will push for it to go in the NHS.
NHS can review their own bleepa data and the new data from private and come and buy it.
Or leave Tom to plod along till the cash runs out and he enthusiastically tells the investors all he needs is another Ā£11m and he is sure he might be able to get another pilot scheme for Ā£200k from somewhere.
I.B.
To go back to my previous point that if NHS UK don't pick this up hard and fast and pay for it they should be cut off from any further "free" tests programmes to leave the remaining cash at bank to support India and UK private contracts.
Look at the pathetic support that post received, most of it from FDBK staff and affiliates, nothing from the NHS
Tom needs it pointing out to him, he is wasting his time and our money ( he hasn't put anything in, or achieved any contract success )
Https://www.linkedin.com/posts/feedback-medical-ltd_cdc-communitydiagnosticcentres-icb-activity-7167888238806818817-htzB
From the above link: 'If you haven't submitted applications to NHS England for the Community diagnostic centre Pathway Development Fund, there is still time - deadline is 29th February.
Good luck with the applications. We look forward to hearing all about the new patient pathways being deployed!
If you need any help with the bids, our team are always here to help (no costs involved and no obligations to use Bleepa) - Just drop me or one of my colleagues a message.
Happy to help.'
Hi Dibs, it is looking encouraging with the awards in India. I suspect that like the NHS, Indian Healthcare budgets will be allocated in the new financial year, so April could be a very busy month on the news front, fingers crossed....
Barnacle - thatās no less than TWO separate Innovation Awards in India in FOUR days for Bleepa. Impressive indeed. Now we can confidently expect this to be translated into incoming business as both these two occasions were great sales and marketing breakthroughs putting us (as Tom would say) āunder the nosesā of all the right connected people within Indiaās healthcare industry.
Anish Patel (CFO) has stated āVery confident of business in the short termā.
Other thing Iād like to mention is the Ā£300k award for the new Pilots is for just THREE months work to 31.3.2024. This would translate to Ā£1.2m if awarded for 12 months equivalent. And that figure is considerably more eye catching when you compare to a paltry current MC @ Ā£9m.
Feedback Medical's innovative secure clinical communications platform Bleepa has the potential to revolutionise healthcare communication practices in India, aligning with the Digital Personal Data Protection Act 2023 hashtag#dpdpact
Recognizing the game-changing potential of this technology and the forward-thinking leadership driving its adoption, HEAL Health has honoured our India Managing Director, Rohit Singh, with the prestigious Next Gen Healthcare Changemaker Award under 45. This accolade was presented at the 8th Health Writers and Influencers Convention in AIIMS, New Delhi on February 21st, cementing our commitment to transforming healthcare communication in India. š
Contracts near term..........
When the UK govt and NHS took the digital innovation monies and gave it to staff as a payrise that should have shown Tom neither are fit for purpose and should be cut out of the loop.
Instead he re gelled his quiff and spent more on giving them freebies, telling them how great it could be.
Anyone whose seen Bleepa and carelocker and then visited a few nhs sites knows its what they need.
I had lunch with a medical professional a while ago, talking a out another system asked him what he thought of Bleepa, he didn't have a clue, when I said its a digital .... he cut me off, waved a hand and laughed, if it's digital and its NHS it won't work, none of them do.
Focus on profit, adding value where it is considered and valued in return.
Reverse
Dibs,
If I was Tom, I would reserve engineer myself into the NHS.
This is part of the issue with him not buying shares, he isn't aligned with share holders and can carry on wasting time on his old mates in the NHS.
I'd cancel all free NHS contracts as they come up for renewal.
Focus on uk private groups, uk insurers, India large groups and license to the USA ins Co's...
Once it's running everywhere else the UK politicians will scrable around for a vote winner and one of these useless lot will front run bleeoa thru the NHS, and they will gladly pay for it as well.
Tom's got it the wrong way round, cut off the freebies, if they can't see it after march/ April then the cash flow demands he focus on profit and not his vanity.
Coffee - not a bad way to look at the opportunity here. India is an absolutely mind blowingly humongous opportunity. It would gulf the NHS many times over. In terms of India I think we have a fantastic foot in the door through the recruitment of Rohit Singh. This guy was with the UK India Business Council for TEN years before joining Feedback six monthās ago. He must have an impressive range of connections with Indian business. That is for sure. So this guy has a network of contacts and a creditable profile known and respected within the Indian business community. I donāt think we, as a very small company, could possibly have a better chance of winning business in India than through this guy. Hell, Bleepa has already won an innovative award in India and he hasnāt even been in the post for six months.
The CFO has stated he is VERY confident of winning new business in the short term. Tom has stated that Rohit has already built a sizeable pipeline of opportunities.
coffee - maybe, just maybe it will be India that opens the floodgates, particularly with the VERY timely introduction of their own Data Protection Act. Perfect. Surely we wonāt snatch defeat from the jaws of impending victory.
Ian,
That's only 300% from here.
I know that sounds a ridiculous statement but If they land Bupa it will do more than that on just one large insurance led contract.
I'm ignoring the NHS opportunities.
Private UK and India medical hospitals and UK & USA Insurance groups
Switched on business savvy fast adopters rather than the tiktok video dancers in a paper mask.
The SP needs to get to Ā£2.23 just to get me back to break even, when is that likely to happen, probably never!!
Tom has options: 533386 (0.7p or Ā£1.40 post consolidation).
Work to do to reach the values below, x200
One-third will vest if the share price reaches at least 1.20p, during the period commencing 31/05/2022 and ending 31/05/2025;
Ā· One-third will vest if the share price reaches at least 1.86p during the period commencing 31/05/2023 and ending 31/05/2025; and
Ā· One-third will vest if the share price reaches at least 3.0p during the period commencing 31/05/2024 and ending 31/05/2025.
Typical AIM Ceo, takes whacking salary and will then award himself options via the "renuneration committee" on the first sniff of a decent contract.
Why hasn't Tom bought any if he's so confident in the Company, that's the question??
Coffee - yes I noticed this too ;)
Confidence indeed.
Dibs,
Agreed, it should also be noted.
Not only has he increased his longer term core holding he has also taken out a spread bet long.
He is very confident!
The guy clearly has his head screwed on then. Speaking of professional investors if you check out FDBK posts on LinkedIn you will often find a number of professional investors and well connected people in the healthcare space liking their posts. I read this as a good indicator and an endorsement of my own interest.